Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29425228 | 1.00 | PAX8 (0.32) | PAX8ALDH1A1 | |
| SCHEMBL10511364 | 1.00 | PAX8 (0.32) | PAX8ALDH1A1 | |
| SCHEMBL30655986 | 1.00 | PAX8 (0.32) | PAX8ALDH1A1 | |
| SCHEMBL29009630 | 1.00 | PAX8 (0.32) | PAX8ALDH1A1 | |
| SCHEMBL524648 | 1.00 | PAX8 (0.32) | PAX8ALDH1A1 | |
| SCHEMBL31006936 | 1.00 | PAX8 (0.32) | PAX8ALDH1A1 | |
| SCHEMBL2510639 | 1.00 | PAX8 (0.32) | PAX8ALDH1A1 | |
| SCHEMBL6384699 | 1.00 | PAX8 (0.32) | PAX8ALDH1A1 | |
| SCHEMBL1673169 | 1.00 | PAX8 (0.32) | PAX8ALDH1A1 | |
| SCHEMBL2693783 | 1.00 | PAX8 (0.32) | PAX8ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 492 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4702138-A1 | PRODUCTION OF A NEGATIVELY CHARGED OLIGOSACCHARIDE BY A CELL | Inbiose N.V. (BE) | 2026-03-04 | — | — | EP | claimed |
| EP-4687966-A2 | IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF | Pfizer Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| EP-4662305-A1 | PRODUCTION OF A DISACCHARIDE AND/OR MILK OLIGOSACCHARIDE BY A CELL WITH REDUCED SYNTHESIS OF UDP-GLCNAC | Inbiose N.V. (BE) | 2025-12-17 | — | — | EP | claimed |
| EP-4662224-A1 | PRODUCTION OF A SACCHARIDE BY A CELL WITH REDUCED SYNTHESIS OF LACTOBIONIC ACID | Inbiose N.V. (BE) | 2025-12-17 | — | — | EP | claimed |
| EP-4608849-A1 | SACCHARIDE IMPORTERS FOR LACTO-N-TRIOSE | Inbiose N.V. (BE) | 2025-09-03 | — | — | EP | claimed |
| US-20250121067-A1 | WATER-SOLUBLE CANNABINOID PRODRUGS COMPOSITIONS AND METHODS OF SYNTHESIZING THE SAME | TRAIT BIOSCIENCES INC (US) | 2025-04-17 | — | — | US | claimed |
| EP-4531836-A1 | WATER-SOLUBLE CANNABINOID PRODRUGS COMPOSITIONS AND METHODS OF SYNTHESIZING THE SAME | Trait Biosciences, Inc. (US) | 2025-04-09 | — | — | EP | claimed |
| US-20240417767-A1 | PRODUCTION OF ALPHA-1,3-FUCOSYLATED COMPOUNDS | INBIOSE N.V. (BE) | 2024-12-19 | — | — | US | claimed |
| US-20240417768-A1 | PRODUCTION OF ALPHA-1,4-FUCOSYLATED COMPOUNDS | INBIOSE NV (BE) | 2024-12-19 | — | — | US | claimed |
| US-20240368651-A1 | CELLULAR PRODUCTION OF DI- AND/OR OLIGOSACCHARIDES | INBIOSE N.V. (BE) | 2024-11-07 | — | — | US | claimed |
| US-20190134200-A1 | USE OF AN AMINO SUGAR AS PLASTICIZER | MERCK PATENT GMBH (DE) | 2019-05-09 | — | — | US | claimed |
| EP-3454837-A1 | USE OF AMINO SUGAR AS PLASTICIZER | Merck Patent GmbH (DE) | 2019-03-20 | — | — | EP | claimed |
| WO-2018187574-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS | CIDARA THERAPEUTICS, INC. (US) | 2018-10-11 | — | — | WO | claimed |
| WO-2017194577-A1 | USE OF AMINO SUGAR AS PLASTICIZER | MERCK PATENT GMBH (DE) | 2017-11-16 | — | — | WO | claimed |
| US-20040030120-A1 | Thauera strain mz1t exopolysachharides | EASTMAN CHEMICAL COMPANY | 2004-02-12 | — | — | US | claimed |
| EP-1268840-A2 | THAUERA STRAIN MZ1T EXOPOLYSACCHARIDES | EASTMAN CHEMICAL COMPANY (US) | 2003-01-02 | — | — | EP | claimed |
| WO-2001075138-A2 | THAUERA STRAIN MZ1T EXOPOLYSACHHARIDES | EASTMAN CHEMICAL COMPANY (US) | 2001-10-11 | — | — | WO | claimed |
| EP-0496351-B1 | Acid heteropolysaccharide, sulfated polysaccharide and process for producing the same | TEIKOKU SEIYAKU KK (JP) | 1996-03-27 | — | — | EP | claimed |
| US-5273892-A | Culturing Pseudomonas | TEIKOKU SEIYAKU KABUSHIKI KAISHA (JP) | 1993-12-28 | — | — | US | claimed |
| EP-0496351-A2 | Acid heteropolysaccharide, sulfated polysaccharide and process for producing the same | TEIKOKU SEIYAKU KABUSHIKI KAISHA (JP) | 1992-07-29 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250121067-A1 | WATER-SOLUBLE CANNABINOID PRODRUGS COMPOSITIONS AND METHODS OF SYNTHESIZING THE SAME | CNR2, CNR1, BSG | PAX8 2240/4885ALDH1A1 3697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.